Multidisciplinary MRI Fusion Prostate Biopsy Program

Prostate cancer remains the most common cancer in men with an estimated 164,690 new cases in 2018. Despite how common prostate cancer is, there are limitations in our ability to detect it based on traditional screening and biopsy methods.

Multi-parametric MRI of the prostate has emerged as a new tool to help urologists detect prostate cancer. Since 2016, at the University of Florida (UF), we have been using the UroNav Fusion Biopsy System to merge a patient’s pre-biopsy MRI images of the prostate with the ultrasound-guided biopsy images in real time to allow for a targeted and more precise prostate biopsy. This system has improved our prostate cancer detection rates in men with a prior negative biopsy and persistently suspicious PSA test as well as helped us better select patients for active surveillance of their prostate cancer.

All patients who undergo a UroNav fusion prostate biopsy at UF have their history and MRI reviewed by our dedicated multidisciplinary team of radiologists, urologists, radiation oncologists and pathologists both before and after the fusion biopsy. This allows us to both optimally plan our fusion biopsies and formulate treatment recommendations if prostate cancer is detected.


Urology


Brandon Otto, MDBrandon J. Otto, MD
Assistant Professor
Department of Urology

Residency:  Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY
Fellowship: Endourology and Minimally Invasive Surgery, University of Florida Department of Urology, College of Medicine, Gainesville, FL
Clinical Interests: Endourology, Robotic and laparoscopic surgery, Kidney Stones, Prostate and Kidney cancer

 

DR. TOM STRINGERThomas F. Stringer, MD
Associate Professor/Associate Chair
Department of Urology

Residency: University of Florida Department of Urology, College of Medicine, Gainesville, FL
Fellowship:  Uro-oncology, Wayne State University, Detroit, MI
Clinical Interests: Prostate Cancer Screening, Benign Prostate Disease, Erectile Dysfunction,  and Urinary Tract Infections


Top of Page


Radiation Oncology


Robert A. Zlotecki, MD, PhDRobert A. Zlotecki, MD, PhD
Professor, Vice Chair of Clinical Affairs, and Medical Director
Radiation Oncology

Residency:  Massachusetts General Hospital, Boston, MA
Research Interests: Soft-tissue sarcomas, Genitourinary cancers, Gastrointestinal tract cancers, Lung cancers, Image-guided and stereotactic body radiation therapy, Selective radiation therapy for liver cancers (RadioEmbolization)


Top of Page


Radiology


 

Joseph R Grajo, MDJoseph R Grajo, MD
Assistant Professor, Abdominal Imaging, Vice Chair for Research, Associate Program Director, Diagnostic Radiology Residency Program, Program Director, Abdominal Imaging Fellowship, Director of Body MRI

Residency: University of South Florida; Tampa, FL (Chief Resident)
Fellowship: Massachusetts General Hospital – Harvard Medical School; Boston, MA (Abdominal Imaging)
Clinical and Research Areas of Interest: Multiparametric prostate MRI with MR/US fusion biopsy, Elastography of the liver for staging fibrosis, MR staging of rectal cancer, Liver MRI following transarterial radioembolization, Noninvasive classification of renal tumors, Imaging of inflammatory bowel disease, Dual Energy CT, Abdominal/pelvic MRI protocol development & structured reporting, Resident/medical student education & research mentoring


Top of Page


Pathology


Sara M FalzaranoSara M Falzarano, MD, PhD
Clinical Assistant Professor

Department of Pathology, Immunology and Laboratory Medicine

Residency:  Cleveland Clinic Foundation, Cleveland, Oh
Skills and Expertise:  Surgical pathology, Prostate cancer

 

picture of dr feelyMichael Feely, DO 
Assistant Professor
Department of Pathology, Immunology and Laboratory Medicine

Residency:  University of Florida, Gainesville, FL

 

 

 


Top of Page